Depomed receives FDA approval of Proquin XR for uncomplicated UTI (PharmaBiz)

home   >   yahoo news

Depomed, Inc. has received approval from the United States Food and Drug Administration (FDA) for Proquin XR, a once-daily, extended-release formulation of ciprofloxacin hydrochloride for the treatment of uncomplicated urinary tract infections (UTIs).

- link to Depomed receives FDA approval of Proquin XR for uncomplicated UTI (PharmaBiz) -
Last update: 06/01/2005

Recommended Reading

    The Cipro payoff. (Names in the News).(Bayer Corp.)(Brief Article) : An article from: Multinational Monitor
    The invisible enemy.(Bayer Corp. increases Cipro production to prevent anthrax infection) : An article from: Medical Update
    Cipro.(New & Approved) : An article from: Pediatric News
    Cipro.(New & Approved) : An article from: Pediatric News
    Campfire Cats Blue Ridge Smoky Mountain Hiking Guide and Journal
    Lonely Planet: Cipro
    Cipro.(New & Approved) : An article from: Pediatric News
    The Cipro Rip-Off. (The Front).(Bayer Corp.) : An article from: Multinational Monitor